Share
3,674 Posts.
lightbulb Created with Sketch. 1738
clock Created with Sketch. 26/11/24
17:33
Share
Originally posted by theone:
↑
I think they will get the 2023 R&D rebate of $11.3m, and I think this will be the next announcement. This will carry them to early 2025 for some data release. However, either they like it or not a Capital Raise (CR) will be forthcoming, I cannot see a Big Pharma choosing to license a Ph1 product, they will at least need to get to Ph2 which means 2026 and more funds needed. If you notice the previous 2 quarterlies, language has changed from:
Expand
Interesting - what on earth is the problem with the rebate?
(20min delay)